Evidence map›Paper›PMID 37941971›Full record

ReviewCancer management and research2023

Profile of Capmatinib for the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC): Patient Selection and Perspectives.

Madison Fraser, Nagashree Seetharamu, Matthew Diamond, Chung-Shien Lee

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancer management and research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Madison FraserDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hofstra University, Hempstead, NY, USA.
Nagashree SeetharamuDivision of Medical Oncology and Hematology, Northwell Health Cancer Institute, Lake Success, NY, USA.ORCID 0000-0002-3282-7622
Matthew DiamondDivision of Medical Oncology and Hematology, Northwell Health Cancer Institute, Lake Success, NY, USA.
Chung-Shien LeeDivision of Medical Oncology and Hematology, Northwell Health Cancer Institute, Lake Success, NY, USA.ORCID 0000-0003-3505-6402
Northwell Health · USHofstra University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aberrant

Indexed as

capmatinibMesenchymal–Epithelial Transition geneMET exon 14 skipping mutationnon-small cell lung cancertyrosine kinase inhibitor

Identifiers

PMID37941971
PMCPMC10629434
OpenAlexW4388302473

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.